We are live on ! Find out more
REVS icon

Columbia Research Enhanced Value ETF

6 hedge funds and large institutions have $1.99M invested in Columbia Research Enhanced Value ETF in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

194% more capital invested

Capital invested by funds: $676K → $1.99M (+$1.31M)

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

50% more funds holding

Funds holding: 46 (+2)

151% less ownership

Funds ownership: 158.89%7.89% (-151%)

Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

REVS Hedge Fund Activity: Q3 2021 in Review

6 of the 5,729 institutional investors tracked by Wall St. Rank reported a position in Columbia Research Enhanced Value ETF (REVS) for Q3 2021, worth a combined $1.99M — up 194% from $676K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new REVS positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $796K. The largest seller was Harbour Investments, cutting an estimated $5.13K.

  • 6 institutional investors held Columbia Research Enhanced Value ETF (REVS) as of Q3 2021, up from 4 in Q2 2021.
  • Funds reported $1.99M of Columbia Research Enhanced Value ETF stock for Q3 2021, up 194% quarter-over-quarter.
  • 2 funds opened new Columbia Research Enhanced Value ETF positions in Q3 2021 and 0 closed out, a net change of +2 holders.
  • The largest Columbia Research Enhanced Value ETF buyer in Q3 2021 was Jane Street, an estimated $796K added.
  • The largest Columbia Research Enhanced Value ETF seller in Q3 2021 was Harbour Investments, an estimated $5.13K sold.

Based on aggregated 13F filings for Q3 2021.